<< CSR 1975-2008 Home

The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 523 KB) and Technical Notes (PDF, 687 KB) pages.



Download and Print: Download Printer-friendly PDF Download data


Table 5.16

Cancer of the Cervix Uteri (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases, 2004-2008
Females by Race
Histologya All Races White Black Asian/
Pacific Islander
American Indian
/Alaska Nativeb
Hispanicc
Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent
Carcinoma 15,406 98.2% 11,706 98.2% 1,972 98.2% 1,403 98.9% 102 97.1% 3,724 98.6%
Epidermoid carcinomad (8050-8131) 10,526 67.1% 7,808 65.5% 1,566 77.9% 925 65.2% 80 76.2% 2,636 69.8%
Squamous cell carcinoma (8070) 6,952 44.3% 5,083 42.6% 1,141 56.8% 593 41.8% 51 48.6% 1,566 41.5%
Squamous cell, keratinizing (8071) 1,137 7.2% 854 7.2% 162 8.1% 100 7.1% - - 345 9.1%
Squamous cell, non-keratinizing (8072) 1,451 9.3% 1,119 9.4% 164 8.2% 135 9.5% - - 439 11.6%
Squamous cell, Microinvasive (8076) 739 4.7% 571 4.8% 66 3.3% 69 4.9% - - 220 5.8%
Other (8050-8069, 8073-8075,8077-8131) 247 1.6% 181 1.5% 33 1.6% 28 2.0% - - 66 1.7%
Adenocarcinomae 4,182 26.7% 3,392 28.4% 292 14.5% 421 29.7% - - 929 24.6%
Adenocarcinoma, NOS (8140) Adenosquamous (8560,8570) 2,166 13.8% 1,761 14.8% 138 6.9% 221 15.6% - - 485 12.8%
683 4.4% 536 4.5% 67 3.3% 72 5.1% - - 174 4.6%
Other adenocarcinomasf 1,333 8.5% 1,095 9.2% 87 4.3% 128 9.0% - - 270 7.1%
Other specific carcinomasg 226 1.4% 177 1.5% 23 1.1% 23 1.6% - - 57 1.5%
Unspecified, Carcinoma, NOS (8010-8011,8020-8022) 472 3.0% 329 2.8% 91 4.5% 34 2.4% - - 102 2.7%
Sarcomah 79 0.5% 63 0.5% - - - - - - 21 0.6%
Other specific types (8720-8790,8930-8936, 8950-9030,9060-9110, 9260-9365,9380-9539) 129 0.8% 98 0.8% 18 0.9% - - - - 19 0.5%
Unspecified (8000-8005) 71 0.5% 57 0.5% - - - - - - - -
Total 15,685 100.0% 11,924 100.0% 2,009 100.0% 1,418 100.0% 105 100.0% 3,778 100.0%

Footnotes:

Source: SEER 17 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta, San Jose-Monterey, Los Angeles, Alaska Native Registry, Rural Georgia, California excluding SF/SJM/LA, Kentucky, Louisiana and New Jersey). Percents may not sum to 100 due to rounding.

a Excludes Kaposi Sarcoma, mesothelioma, lymphomas, leukemias, myelomas, lymphoreticular, and immunoproliferative diseases.

b Estimates for American Indian/Alaska Native are based on the CHSDA(Contract Health Service Delivery Area) counties.

c Hispanic is not mutually exclusive from whites, blacks, Asian/Pacific Islanders, and American Indians/Alaska Natives. Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry.

d Epidermoid carcinoma includes squamous, basal, and transitional cell carcinomas.

e Adenocarcinoma includes histologies 8140-8147,8160-8162,8180-8221,8250-8507,8514,8520-8551,8560,8570-8574,8576,8940-8941.

f Other adenocarcinomas include histologies 8141-8147,8160-8162,8180-8221,8250-8507,8514,8520-8551,8571-8574,8576,8940-8941.

g Other specific carcinomas include histologies 8012-8015,8030-8046,8150-8155,8170-8175,8230-8249,8508,8510-8513,8561-8562, 8575,8580-8671.

h Sarcoma includes histologies 8680-8713,8800-8921,9040-9044,9120-9136,9150-9252,9370-9373,9540-9582.

- Statistic not shown due to fewer than 16 cases during the time period.

Page Navigation: << Previous Next >>


The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.